Thromboinflammation in ischemic cerebrovascular patients with the JAK2V617F mutation
In ischemic cerebrovascular patients, the JAK2V617F mutation is associated with elevated markers of endothelial dysfunction and chronic inflammation. This underscores the role of inflammation in thrombosis driven by the JAK2V617F mutation.
Authors
- Laura Massarenti (ORCID: https://orcid.org/0000-0001-5647-4617)
- Christian Enevold (ORCID: https://orcid.org/0000-0002-2748-1997)
- Lasse Kjær (ORCID: https://orcid.org/0000-0001-6767-0226)
- Troels Wienecke (ORCID: https://orcid.org/0000-0002-5389-1105)
- Marie Hvelplund Kristiansen (ORCID: https://orcid.org/0000-0003-4285-6766)
- Hans Carl Hasselbalch (ORCID: https://orcid.org/0000-0003-3936-8032)
- Claus Henrik Nielsen (ORCID: https://orcid.org/0000-0001-7543-9016)
- Sisse Rye Ostrowski (ORCID: https://orcid.org/0000-0001-5288-3851)
- Morten Kranker Larsen (ORCID: https://orcid.org/0000-0002-2873-5928)
- Vibe Skov (ORCID: https://orcid.org/0000-0003-0097-7826)
Institutions
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
- Zealand University Hospital (DK)
Publication Details
- Journal
- Thrombosis Research
- Published
- 2024-12-06
- DOI
- https://doi.org/10.1016/j.thromres.2024.109236
- Citations
- 5
- Primary Topic
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.19
Funders
- Toyota Foundation
- Snedkermester Sophus Jacobsen og Hustru Astrid Jacobsens Fond
- Rigshospitalet
- Harboefonden
- Region Sjælland
- Grosserer A.V. Lykfeldt og Hustrus Legat
- Fabrikant Einar Willumsens Mindelegat
- Sjællands Universitetshospital
- Greater Copenhagen Health Science Partners
- Fonden til Lægevidenskabens Fremme